To specifically examine the anti-tumor activity of BSN on A549 cells, the cells were treated with the indicated concentrations of BSN, and then cell viability was analyzed every 15 min time intervals using the xCELLigence RTCA MP Instrument (Roche Diagnostics GmbH, Germany). Here, BSN is linked to neoplasm.